OMEROmeros Corporation

$821M

Q3 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$30M+547.9% YoY

Gross Profit

$30M99.1% margin

Operating Income

-$11M-37.2% margin

Net Income

-$16M-55.1% margin

EPS (Diluted)

$-0.33

QoQ Revenue Growth

+11.6%

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$8M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$91M

Total Liabilities

$231M

Stockholders' Equity

-$140M

Cash & Equivalents

$9M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$30M	$5M	+547.9%
Gross Profit	$30M	$5M	+546.9%
Operating Income	-$11M	-$35M	+68.7%
Net Income	-$16M	-$39M	+58.3%

OMER Q3 2019 Earnings — Omeros Corporation Revenue & Financial Results | Market Cap Arena